At a glance
DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award is a federal competitive grant from Defense Health Agency Contracting Activity - DHACA for the science & technology sector. Funding: 4500000. Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The application deadline is October 1, 2026. Apply via the official listing at www.grants.gov.
- Amount
- $4.5M total
- Deadline
- Oct 1, 2026
- Type
- Competitive
- Status
- Closing soon
About this program
Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the OCA is to conduct innovative and impactful ovarian cancer research while developing successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.Distinctive Features: The OCA is a virtual career development and research training platform that consists of Early-Career Investigators (ECIs), their Designated Mentors, and an Academy Dean and Assistant Dean. The OCA-ECI Award is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, Mentors, the Dean and Assistant Dean) as well as with the advocacy community.
Who can apply
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
How to apply
Apply through Grants.gov using funding opportunity number HT942526OCRPOCAECI. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) NIH · Up to $25K · Jan 7, 2028 Open
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) NIH · Up to $100K · Nov 16, 2027 Open
- NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) NIH · Up to $150K · Jan 7, 2028 Open
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) NIH · See listing · Jan 7, 2027 Open